2346 related articles for article (PubMed ID: 23831213)
1. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
3. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
4. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
5. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia.
Ishii H; Mukae H; Kadota J; Fujii T; Abe K; Ashitani J; Kohno S
Respiration; 2005; 72(1):39-45. PubMed ID: 15753633
[TBL] [Abstract][Full Text] [Related]
7. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
[TBL] [Abstract][Full Text] [Related]
9. CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis.
Capelli A; Di Stefano A; Gnemmi I; Donner CF
Eur Respir J; 2005 Apr; 25(4):701-7. PubMed ID: 15802346
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
11. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Prasse A; Pechkovsky DV; Toews GB; Jungraithmayr W; Kollert F; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G
Am J Respir Crit Care Med; 2006 Apr; 173(7):781-92. PubMed ID: 16415274
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage in idiopathic interstitial lung diseases.
Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T
Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777
[TBL] [Abstract][Full Text] [Related]
13. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs).
Kopiński P; Balicka-Ślusarczyk B; Dyczek A; Szpechciński A; Przybylski G; Jarzemska A; Wandtke T; Jankowski M; Iwaniec T; Chorostowska-Wynimko J
Folia Histochem Cytobiol; 2011; 49(4):636-45. PubMed ID: 22252758
[TBL] [Abstract][Full Text] [Related]
15. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.
Shinoda H; Tasaka S; Fujishima S; Yamasawa W; Miyamoto K; Nakano Y; Kamata H; Hasegawa N; Ishizaka A
Respiration; 2009; 78(3):285-92. PubMed ID: 19270434
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
[No Abstract] [Full Text] [Related]
17. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia.
Cai M; Bonella F; Dai H; Sarria R; Guzman J; Costabel U
Immunobiology; 2013 Jun; 218(6):930-7. PubMed ID: 23199585
[TBL] [Abstract][Full Text] [Related]
18. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
19. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
